Physician profile
Robert Gonzalez
NPI 1457363434
$1,247.17
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.57 · 2020: $108 · 2021: $650 · 2022: $457 · 2023: $15.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $175.75 | 2019-2022 | |
| Novo Nordisk INC | $174.39 | 2020-2022 | |
| Abbvie INC. | $164.82 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $152.52 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.42 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.11 | 2021-2022 | |
| Amarin Pharma, INC. | $73.69 | 2021-2022 | |
| Eisai INC. | $46.66 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.19 | 2021-2022 | |
| Nevro Corp. | $33.66 | 2022 | |
| Daiichi Sankyo INC. | $24.64 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $24.18 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $22.68 | 2021 | |
| Medtronic, INC. | $19.60 | 2022 | |
| Radius Health, INC. | $15.62 | 2023 | Tymlos |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $15.15 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.04 | 2022 | |
| Astellas Pharma US INC | $12.53 | 2021 | |
| Pfizer INC. | $12.13 | 2022 | |
| Glaxosmithkline, LLC. | $12.10 | 2021 | |
| Sunovion Pharmaceuticals INC. | $11.96 | 2021 | |
| Lilly USA, LLC | $11.66 | 2021 | |
| Abbott Laboratories | $11.57 | 2021 | |
| Esperion Therapeutics, INC. | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.